Hims & hers appoints tenured pharmaceutical, regulatory, and quality experts to key leadership positions

San francisco--(business wire)--hims & hers health, inc. (“hims & hers”) (nyse: hims), the leading health and wellness platform, today announced deb autor, former deputy commissioner at the fda, will join the company's board of directors, and janet stevens, a pharmaceutical quality expert, will join the company as global head of quality & safety. hims & hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confiden.
HIMS Ratings Summary
HIMS Quant Ranking